HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B Thürlimann Selected Research

Pain (Aches)

8/2002Vinorelbine in androgen-independent metastatic prostatic carcinoma--a phase II study.
2/2000Response and palliation in a phase II trial of gemcitabine in hormone-refractory metastatic prostatic carcinoma. Swiss Group for Clinical Cancer Research (SAKK).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


B Thürlimann Research Topics

Disease

62Breast Neoplasms (Breast Cancer)
10/2021 - 02/2000
26Neoplasms (Cancer)
01/2017 - 02/2000
5Neoplasm Metastasis (Metastasis)
07/2008 - 12/2000
4Uterine Hemorrhage (Uterine Bleeding)
08/2003 - 09/2000
2Noninfiltrating Intraductal Carcinoma (DCIS)
01/2017 - 12/2003
2Osteoporosis
06/2012 - 09/2009
2Bone Diseases (Bone Disease)
05/2011 - 03/2008
2Pain (Aches)
08/2002 - 02/2000
2Carcinoma (Carcinomatosis)
08/2002 - 02/2000
2Prostatic Neoplasms (Prostate Cancer)
08/2002 - 02/2000
1Disease Progression
01/2017
1Residual Neoplasm
01/2017
1Primary Ovarian Insufficiency
08/2015
1Myalgia
01/2014
1Arthralgia (Joint Pain)
01/2014
1Lymphadenopathy
01/2013
1Fatigue
05/2012
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
09/2011
1Hyperlipidemias (Hyperlipidemia)
09/2011
1Hyperlipoproteinemias
09/2011
1Hypercholesterolemia
09/2011
1Hand-Foot Syndrome
09/2011
1Bone Fractures (Bone Fracture)
09/2009
1Metabolic Bone Diseases (Osteopenia)
03/2008
1Endocrine System Diseases (Endocrine Diseases)
10/2005
1Asthenia
04/2003
1Nausea
01/2002
1Vomiting
01/2002
1Febrile Neutropenia
08/2000

Drug/Important Bio-Agent (IBA)

22TamoxifenFDA LinkGeneric
12/2015 - 04/2000
12Hormones (Hormone)IBA
12/2015 - 02/2000
7Letrozole (Femara)FDA LinkGeneric
12/2015 - 06/2005
7Anastrozole (Arimidex)FDA LinkGeneric
11/2006 - 09/2000
6Aromatase InhibitorsIBA
10/2011 - 08/2001
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
08/2008 - 04/2000
6Methotrexate (Mexate)FDA LinkGeneric
08/2008 - 04/2000
6Fluorouracil (Carac)FDA LinkGeneric
08/2008 - 04/2000
5Progesterone Receptors (Progesterone Receptor)IBA
09/2007 - 11/2001
5Estrogen ReceptorsIBA
05/2005 - 02/2000
4Trastuzumab (Herceptin)FDA Link
01/2017 - 04/2003
4Diphosphonates (Bisphosphonates)IBA
01/2017 - 12/2000
4AnthracyclinesIBA
08/2015 - 08/2000
4Docetaxel (Taxotere)FDA Link
05/2013 - 08/2000
4Estrogens (Estrogen)FDA Link
09/2007 - 08/2001
3Paclitaxel (Taxol)FDA LinkGeneric
08/2015 - 04/2003
2Biological ProductsIBA
10/2021 - 08/2011
2Taxoids (Taxanes)IBA
10/2005 - 08/2000
2Vinorelbine (Navelbine)FDA LinkGeneric
12/2004 - 08/2002
2thiamine triphosphorate (TTP)IBA
08/2003 - 11/2001
2Analgesics (Analgesic Drugs)IBA
08/2002 - 02/2000
1Gonadotropin-Releasing Hormone (GnRH)FDA Link
08/2015
1Doxorubicin (Adriamycin)FDA LinkGeneric
05/2013
1Triglycerides (Triacylglycerol)IBA
09/2011
1liposomal doxorubicin (Doxil)FDA Link
09/2011
1Bevacizumab (Avastin)FDA Link
09/2011
1Procollagen Type IIBA
05/2011
1exemestane (Aromasin)FDA Link
07/2008
1Ibandronic Acid (Boniva)FDA Link
07/2008
1human ERBB2 proteinIBA
07/2008
1Zoledronic Acid (Zometa)FDA Link
03/2008
1Clodronic Acid (Clodronate)IBA
03/2008
1Biomarkers (Surrogate Marker)IBA
04/2007
1Alkaline PhosphataseIBA
04/2007
1Indicators and Reagents (Reagents)IBA
04/2007
1Estrogen Receptor AntagonistsIBA
01/2007
1Toremifene (Fareston)FDA Link
01/2007
1Fulvestrant (Faslodex)FDA Link
01/2007
1EndostatinsIBA
02/2006
1ErythropoietinFDA Link
02/2006
1EndoglinIBA
02/2006
1taxaneIBA
02/2006
1erucylphosphocholineIBA
02/2006
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2006
1Angiopoietin-2IBA
02/2006
1Capecitabine (Xeloda)FDA Link
12/2004
1AndrogensIBA
08/2002
1Prostate-Specific Antigen (Semenogelase)IBA
08/2002
1Pharmaceutical PreparationsIBA
08/2002
1lipid-associated sialic acid (LASA)IBA
01/2002
1SteroidsIBA
11/2001
1Proteins (Proteins, Gene)FDA Link
11/2001
1Drug CombinationsIBA
03/2001
1Epirubicin (Ellence)FDA LinkGeneric
03/2001
1Dihydrotachysterol (AT 10)IBA
12/2000
1Anti-Bacterial Agents (Antibiotics)IBA
08/2000

Therapy/Procedure

40Therapeutics
10/2021 - 09/2000
22Drug Therapy (Chemotherapy)
01/2017 - 02/2000
5Radiotherapy
09/2013 - 08/2000
3Neoadjuvant Therapy
10/2021 - 02/2006
2Mastectomy (Mammectomy)
11/2012 - 04/2003
2Hormone Replacement Therapy (Therapy, Hormone Replacement)
06/2012 - 09/2009
2Combination Drug Therapy (Combination Chemotherapy)
08/2008 - 06/2002
2Adjuvant Chemotherapy
06/2002 - 02/2000
1Segmental Mastectomy (Lumpectomy)
01/2013
1Hysterectomy
06/2012
1Aftercare (After-Treatment)
05/2012
1Oral Administration
03/2008
1Renal Dialysis (Hemodialysis)
11/2006
1Modified Radical Mastectomy (Mastectomy, Modified)
04/2003
1Orchiectomy (Orchidectomy)
08/2002